GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) » Definitions » E10

Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) E10 : HK$0.12 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2024 was HK$0.115. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is HK$0.12 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Shenzhen Hepalink Pharmaceutical Group Co's average E10 Growth Rate was -15.90% per year. During the past 3 years, the average E10 Growth Rate was -8.90% per year. During the past 5 years, the average E10 Growth Rate was -8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Shenzhen Hepalink Pharmaceutical Group Co was -8.10% per year. The lowest was -9.10% per year. And the median was -8.90% per year.

As of today (2024-06-10), Shenzhen Hepalink Pharmaceutical Group Co's current stock price is HK$3.34. Shenzhen Hepalink Pharmaceutical Group Co's E10 for the quarter that ended in Mar. 2024 was HK$0.12. Shenzhen Hepalink Pharmaceutical Group Co's Shiller PE Ratio of today is 27.83.

During the past 13 years, the highest Shiller PE Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 49.98. The lowest was 20.62. And the median was 33.33.


Shenzhen Hepalink Pharmaceutical Group Co E10 Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co E10 Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.34 0.21 0.19 0.11

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.16 0.15 0.11 0.12

Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Shiller PE Ratio falls into.



Shenzhen Hepalink Pharmaceutical Group Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shenzhen Hepalink Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.115/115.2271*115.2271
=0.115

Current CPI (Mar. 2024) = 115.2271.

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data

per share eps CPI Adj_EPS
201406 0.039 98.200 0.046
201409 0.111 98.900 0.129
201412 0.112 99.000 0.130
201503 0.179 99.900 0.206
201506 0.083 99.500 0.096
201509 0.146 100.500 0.167
201512 0.153 100.600 0.175
201603 0.187 102.200 0.211
201606 0.062 101.400 0.070
201609 0.035 102.400 0.039
201612 0.086 102.600 0.097
201703 -0.011 103.200 -0.012
201706 0.018 103.100 0.020
201709 0.075 104.100 0.083
201712 0.108 104.500 0.119
201803 0.069 105.300 0.076
201806 0.151 104.900 0.166
201809 0.189 106.600 0.204
201812 0.128 106.500 0.138
201903 0.475 107.700 0.508
201906 0.036 107.700 0.039
201909 0.110 109.800 0.115
201912 0.346 111.200 0.359
202003 0.226 112.300 0.232
202006 0.286 110.400 0.299
202009 0.104 111.700 0.107
202012 0.249 111.500 0.257
202103 0.117 112.662 0.120
202106 0.160 111.769 0.165
202109 0.101 112.215 0.104
202112 -0.184 113.108 -0.187
202203 0.197 114.335 0.199
202206 0.221 114.558 0.222
202209 0.107 115.339 0.107
202212 0.057 115.116 0.057
202303 0.052 115.116 0.052
202306 0.042 114.558 0.042
202309 0.014 115.339 0.014
202312 -0.691 114.781 -0.694
202403 0.115 115.227 0.115

Add all the adjusted EPS together and divide 10 will get our e10.


Shenzhen Hepalink Pharmaceutical Group Co  (HKSE:09989) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shenzhen Hepalink Pharmaceutical Group Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3.34/0.12
=27.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 49.98. The lowest was 20.62. And the median was 33.33.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shenzhen Hepalink Pharmaceutical Group Co E10 Related Terms

Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business and Others. Geographical presence of company is in Hong Kong, United States of America, Europe, Mainland China and Other countries. Majority of the company's revenue comes from USA and Europe.
Executives
Orbimed Capital Llc 2102 Investment manager
Morgan Stanley & Co. International Plc 2105 Underwriter
Morgan Stanley International Holdings Inc. 2201 Interest of corporation controlled by you
Morgan Stanley International Limited 2201 Interest of corporation controlled by you
Morgan Stanley Investments (uk) 2201 Interest of corporation controlled by you
Avict Global Holdings Limited 2101 Beneficial owner
Worldwide Healthcare Trust Plc 2101 Beneficial owner

Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Headlines

No Headlines